scholarly article | Q13442814 |
P50 | author | Natasha Sarah Crowcroft | Q61100890 |
Sarah A Buchan | Q89301868 | ||
P2093 | author name string | Mark Loeb | |
Jeffrey C Kwong | |||
Margaret L Russell | |||
Lawrence W Svenson | |||
Steven J Drews | |||
Allison N Scott | |||
Kimberley A Simmonds | |||
Bryna F Warshawsky | |||
Stephanie Booth | |||
P2860 | cites work | Emergence of a novel swine-origin influenza A (H1N1) virus in humans | Q29616833 |
Design and validation of real-time reverse transcription-PCR assays for detection of pandemic (H1N1) 2009 virus. | Q30380347 | ||
Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated | Q30381731 | ||
Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach | Q30383722 | ||
Ascertainment of chronic diseases using population health data: a comparison of health administrative data and patient self-report | Q30533329 | ||
Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation | Q34051146 | ||
Effectiveness of the 2012/13 trivalent live and inactivated influenza vaccines in children and adolescents in Saxony-Anhalt, Germany: a test-negative case-control study | Q35465093 | ||
Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine | Q36518793 | ||
Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings | Q36783905 | ||
Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16. | Q37355256 | ||
Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. | Q37355265 | ||
Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference | Q37919891 | ||
Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season | Q38378102 | ||
2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type | Q38410159 | ||
Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season | Q38415770 | ||
The test-negative design for estimating influenza vaccine effectiveness | Q38427246 | ||
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 | ||
Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere | Q40074131 | ||
Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season | Q40089214 | ||
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results | Q40357312 | ||
Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children: A Cluster Randomized Blinded Trial. | Q40476706 | ||
Prevention and Control of Seasonal Influenza with Vaccines | Q40607746 | ||
Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States | Q41109359 | ||
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season | Q41510283 | ||
Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015-2016: A Systematic Review and Meta-Analysis | Q41510419 | ||
2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States | Q46251130 | ||
Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017-2018. | Q54958007 | ||
The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies | Q82878184 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Canada | Q16 |
influenza vaccine | Q383260 | ||
attenuated vaccine | Q1810913 | ||
P304 | page(s) | e181514 | |
P577 | publication date | 2018-09-01 | |
P1433 | published in | JAMA Pediatrics | Q4787306 |
P1476 | title | Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study | |
P478 | volume | 172 |
Q59351771 | Evaluation of the field-protective effectiveness of seasonal influenza vaccine among Korean children aged < 5 years during the 2014-2015 and 2015-2016 influenza seasons: a cohort study |
Q64135434 | Immunogenicity and viral shedding of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled trial among pre-school aged children in urban Bangladesh |
Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
Q92604918 | Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes |
Search more.